UC BON.CAP.CERT. 03/25 NEM/ DE000HD41W94 /
15/05/2024 11:45:19 | Diferencia+0.610 | Bid13:02:31 | Ask13:02:31 | Subyacente | Precio de ejercicio | Fecha de expiración | Tipo de opción |
---|---|---|---|---|---|---|---|
90.460EUR | +0.68% | 90.240 Volumen de oferta: 1,000 |
90.290 Tamaño/ Volumen/ Formato de Ask: 1,000 |
NEMETSCHEK SE O.N. | - - | 28/03/2025 | Call |
GlobeNewswire
13:03
Unicycive Therapeutics Presents Bioequivalence Data on Oxylanthanum Carbonate (OLC) at the National ...
GlobeNewswire
13:01
Olema Oncology Announces Promising New Data for Palazestrant in Combination with Ribociclib Presente...
GlobeNewswire
13:00
BiomX to Host First Quarter 2024 Financial Results Conference Call and Webcast on May 21, 2024
GlobeNewswire
13:00
Edible Garden Reports Significant 27.6% Year-Over-Year Revenue Growth for First Quarter of 2024
GlobeNewswire
13:00
Dorman Products expands its catalog of cost-saving and aftermarket-exclusive repair solutions
GlobeNewswire
13:00
Plug to Revolutionize Middle-Mile Delivery with Class 6 Fuel Cell Electric Truck Integration
GlobeNewswire
13:00
Cabaletta Bio Reports First Quarter 2024 Financial Results and Provides Business Update
GlobeNewswire
13:00
Perspective Therapeutics Provides Recent Business Highlights and Reports Fiscal Q1 2024 Results
GlobeNewswire
13:00
Boralex announces a substantial 62% increase in net earnings and continued disciplined development o...
GlobeNewswire
13:00
T2 Biosystems Announces $8 Million Private Placement Priced At-The-Market Under Nasdaq Rules
GlobeNewswire
13:00
TFF Pharmaceuticals Provides Update on Tacrolimus Inhalation Powder (TFF TAC) Phase 2 Trial for the ...
GlobeNewswire
13:00
Creative Realities Inc. plans its expansion into EMEA and announces its beta launch to EMEA Integrat...
- Primera página
- Atrás
- 1
- 2
- 3
- 4
- Siguiente
- Última página